It is unfortunate, but progress in understanding the biology of prostate cancer has been slow because of 1) our limited understanding of the factors that control the growth and differentiation of the prostate gland, 2) the inherent difficulties involved in studying how changes in genotype contribute to such a heterogeneous disease in a heterogeneous population, and 3) the paucity of animal models that faithfully mimic, both temporally and spatially, the progressive stages associated with clinical prostate cancer. Clearly, these observations underscore the need to develop, characterize and disseminate relevant model systems with defined genetic backgrounds that accurately and reproducibly display heritable, and progressive prostate malignancies. Hence, the long term goal of this competing continuation application by the Baylor College of Medicine (BCM) Texas A&M University (TAMU) and University of Western Ontario (UWO) group is to leverage our expertise in the generation, characterization and application of germ-line mouse models and build on our record of achievement in prostate cancer research to function as an integral component of the NCI Mouse Models for Human Cancers Consortium (MMHCC). In this application, we present seven integrated projects (five at BCM, one at TAMU and one at UWO) all designed to generate, characterize and disseminate important genetically engineered mouse models in order to (a) facilitate identification and examination of molecular mechanisms responsible for initiation, progression and metastasis of prostate cancer and (b) hasten the development and translation of efficacious strategies for prevention, diagnosis and therapy. The projects will attempt to establish new models to investigate genomic instability, metastasis, cell death, cell growth, provide real time non invasive imaging, and understand the role of the microenvironment and deregulated growth factor signaling in prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA084296-09
Application #
7224125
Study Section
Special Emphasis Panel (ZCA1-SRRB-U (J1))
Program Officer
Marks, Cheryl L
Project Start
1999-09-30
Project End
2009-03-31
Budget Start
2007-05-16
Budget End
2008-03-31
Support Year
9
Fiscal Year
2007
Total Cost
$1,107,477
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Carstens, Julienne L; Shahi, Payam; Van Tsang, Susan et al. (2014) FGFR1-WNT-TGF-? signaling in prostate cancer mouse models recapitulates human reactive stroma. Cancer Res 74:609-20
Yang, Feng; Chen, Yizhen; Shen, Tao et al. (2014) Stromal TGF-? signaling induces AR activation in prostate cancer. Oncotarget 5:10854-69
Yang, Feng; Zhang, Yongyou; Ressler, Steven J et al. (2013) FGFR1 is essential for prostate cancer progression and metastasis. Cancer Res 73:3716-24
Valiyeva, Fatma; Jiang, Fei; Elmaadawi, Ahmed et al. (2011) Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models. Mol Cancer Ther 10:1229-40
Shafer-Weaver, Kimberly A; Watkins, Stephanie K; Anderson, Michael J et al. (2009) Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res 69:6256-64
Acevedo, Victor D; Ittmann, Michael; Spencer, David M (2009) Paths of FGFR-driven tumorigenesis. Cell Cycle 8:580-8
Watanabe, Masami; Yang, Guang; Cao, Guangwen et al. (2009) Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression. Mol Cancer Res 7:1446-55
Schauer, Isaiah G; Ressler, Steven J; Rowley, David R (2009) Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model. Prostate 69:373-84
Xuan, Jim W; Bygrave, Michael; Valiyeva, Fatma et al. (2009) Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model. Mol Imaging 8:209-20
Schauer, Isaiah G; Ressler, Steven J; Tuxhorn, Jennifer A et al. (2008) Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 72:205-13

Showing the most recent 10 out of 58 publications